| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/09/2003 | US20030190641 Live cell method for observing cellular processes |
| 10/09/2003 | US20030190639 Diagnosis of Cryptogenetic inflammatory bowel diseases (IBDs) |
| 10/09/2003 | US20030190633 Support for fixing nucleotide and process for producing the same |
| 10/09/2003 | US20030190628 Beads, preparing method for the same, flow cytometer and program |
| 10/09/2003 | US20030190624 For assessing kidney function; diagnosing, staging, treating and evaluating therapies for such disorders |
| 10/09/2003 | US20030190616 Differentially methylated sequences in pancreatic cancer |
| 10/09/2003 | US20030190615 DPI-6, a putative therapeutic target and biomarker in neuropsychiatric and neurological disorders |
| 10/09/2003 | US20030190614 Non-human primate Fc receptors and methods of use |
| 10/09/2003 | US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 10/09/2003 | US20030190611 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/09/2003 | US20030190610 Proteins involved in differentiation, maintenance of multicellular organisms, e.g. proliferation, migration, interaction of cells through drugs |
| 10/09/2003 | US20030190603 Method and system for predicting therapeutic agent resistance and for defining the genetic basis of drug resistance using neural networks |
| 10/09/2003 | US20030190602 Cell-based detection and differentiation of disease states |
| 10/09/2003 | US20030190601 Useful for diagnosis and therapy, research tools for drug discovery |
| 10/09/2003 | US20030190600 Used in treatments for bacterial infections, dysentery, angiogenesis, immune cell mediated disease |
| 10/09/2003 | US20030190599 Combinational Biosensor |
| 10/09/2003 | US20030190597 For drug screening and development, exposing to a compound that paralyzes or kills nematoda |
| 10/09/2003 | US20030190407 Comprises impregnated carrier layer having communicating pore space with probe contained therein formed of biomolecules |
| 10/09/2003 | US20030190368 Identification of cellular activation factors and their use as diagnostic markers |
| 10/09/2003 | US20030190328 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 10/09/2003 | US20030190315 Reducing antibody-mediated lipid peroxidation activity in vascular systems; idiotypic antibodies; chlamydia pneumoniae vaccines |
| 10/09/2003 | US20030190313 Immunoglobulins; lipopolysaccharides; immunoassay; kits |
| 10/09/2003 | US20030190311 Immunoglobulins; fusion proteins; vaccines |
| 10/09/2003 | US20030190285 Having nucleotide sequence of any one of the strands of any one of the members of the High Mobility Group protein genes or LIM protein genes, including modified versions and derivatives thereof; diagnostic and therapeutic applications |
| 10/09/2003 | US20030190266 Odor eliminating fiber structure having indicator |
| 10/09/2003 | US20030190262 Employ luminescence-quenching to produce a signal indicative of oxygen concentration |
| 10/09/2003 | US20030190261 Detects concentration of gas circulating inside an outlet-side piping in high accurate manner; contains a through hole in an inner wall of outlet side piping and a gas inlet portion with one face open within the outlet-side piping |
| 10/09/2003 | US20030189969 Method to calculate fuel DI number from a measured curve |
| 10/09/2003 | US20030189968 Method and apparatus for evaluating the phase changing function of fabric |
| 10/09/2003 | US20030189850 Cell array system |
| 10/09/2003 | US20030188970 Electrophoresis separation apparatus and its used a hand-held electrophoresis detection device |
| 10/09/2003 | US20030188953 Method and apparatus for inspecting articles of glassware |
| 10/09/2003 | US20030188591 Concrete test specimen method and apparatus |
| 10/09/2003 | US20030188590 Apparatus and methods for determining self-weight consolidation and other properties of media |
| 10/09/2003 | US20030188570 System and method for determining oil grade |
| 10/09/2003 | US20030188568 Gas sensor, gas sensor installation structure, and method for installing gas sensor |
| 10/09/2003 | US20030188427 Process for producing an electrochemical biosensor |
| 10/09/2003 | DE10215909C1 Verfahren und Vorrichtung zur Überwachung der Wasserstoffkonzentration Method and apparatus for monitoring the concentration of hydrogen |
| 10/09/2003 | CA2738579A1 Improving performance of an analyte monitoring device |
| 10/09/2003 | CA2724741A1 Integrated sample testing meter |
| 10/09/2003 | CA2488233A1 Cell population with identification codes and method of screening cell population |
| 10/09/2003 | CA2481376A1 Novel proteins and nucleic acids encoding same |
| 10/09/2003 | CA2481232A1 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 10/09/2003 | CA2480770A1 Biochip sensor surface carrying polyethylene glycolated nanoparticles |
| 10/09/2003 | CA2480694A1 Ox40r binding agents |
| 10/09/2003 | CA2480673A1 Methods and compositions for detection and quantitation of nucleic acid analytes |
| 10/09/2003 | CA2480664A1 Cancer associated protein phosphatases and their uses |
| 10/09/2003 | CA2480635A1 Cancer associated protein kinases and their uses |
| 10/09/2003 | CA2480525A1 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification |
| 10/09/2003 | CA2480434A1 Novel integrated circuit chip for bioassays |
| 10/09/2003 | CA2480286A1 Disruption of the redk gene |
| 10/09/2003 | CA2480227A1 Neuroprotectant methods, compositions, and screening methods thereof |
| 10/09/2003 | CA2480216A1 Human metabolic models and methods |
| 10/09/2003 | CA2480170A1 Hybrid phosphoinositide phospholipids: compositions and uses |
| 10/09/2003 | CA2480160A1 Multiplex standardized reverse transcriptase-polymerase chain reaction method for assessment of gene expression in small biological samples |
| 10/09/2003 | CA2480119A1 Cripto-specific antibodies |
| 10/09/2003 | CA2480055A1 System and method for managing a patient treatment program |
| 10/09/2003 | CA2479750A1 Fibrinogen binding moieties |
| 10/09/2003 | CA2479379A1 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| 10/09/2003 | CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 10/09/2003 | CA2476352A1 Methods for selecting treatment regimens and predicting outcomes in cancer patients |
| 10/09/2003 | CA2474512A1 Method for producing pseudo islets |
| 10/09/2003 | CA2448584A1 Integrated sample testing meter |
| 10/09/2003 | CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 10/08/2003 | EP1351058A1 Fluorescence-based mucus assay |
| 10/08/2003 | EP1351057A1 Inhibitors of caspase-3-mediated cleavage of essential ventricular myosin light chain |
| 10/08/2003 | EP1351056A2 Specific bonding analysis method and capillary tube device therefor |
| 10/08/2003 | EP1351055A2 Test strip containers and methods of using the same |
| 10/08/2003 | EP1351054A2 Installation structure for gas sensor |
| 10/08/2003 | EP1351053A1 Method for preparing fragrance composition with plurality of sampling ports |
| 10/08/2003 | EP1350855A2 Array based hybridization assays |
| 10/08/2003 | EP1350851A1 Method of detecting polymorphism in dna by using mass spectroscopy |
| 10/08/2003 | EP1350848A2 T-cell membrane protein (TIRC7), gene encoding it and antibodies against it and uses thereof |
| 10/08/2003 | EP1350847A1 Human glioma antigen and process for preparing the same |
| 10/08/2003 | EP1350839A1 Identification of virulence associated regions RD1 and RD5 enabling the development of improved vaccines of M. bovis BCG and M. microti |
| 10/08/2003 | EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor |
| 10/08/2003 | EP1350798A1 Allergenic protein HEV b III of natural rubber latex, its production and use in assays |
| 10/08/2003 | EP1350797A1 Allergenic protein Hev b II of natural rubber latex, its production and use in assays |
| 10/08/2003 | EP1350568A1 Biochannel assay for hybridization with biomaterial |
| 10/08/2003 | EP1350464A1 Method of verifying the efficacy of a skin product |
| 10/08/2003 | EP1350333A2 Local oscillator leakage control in direct conversion processes |
| 10/08/2003 | EP1350179A2 Methods and systems for evaluating a matching between measured data and standards |
| 10/08/2003 | EP1350121A2 Sea-trosy and related methods |
| 10/08/2003 | EP1350116A1 Method of compensating for drift in gas sensing equipment |
| 10/08/2003 | EP1350115A2 Structure-based methods for assessing amino acid variances |
| 10/08/2003 | EP1350114A2 Detection of survivin in the biological fluids of cancer patients |
| 10/08/2003 | EP1350113A2 Inhibition of cmv infection and dissemination |
| 10/08/2003 | EP1350112A2 Methods for the treatment of ibs |
| 10/08/2003 | EP1350111A2 Detection of allergen-specific ige |
| 10/08/2003 | EP1350110A2 Methods for conducting assays, and devices for use therein |
| 10/08/2003 | EP1350109A1 Marker for inflammatory conditions |
| 10/08/2003 | EP1350108A2 Method for identifying a ligand for a biological substrate |
| 10/08/2003 | EP1350107A2 Method and device for characterising and/or for detecting a bonding complex |
| 10/08/2003 | EP1350106A2 Ultra-sensitive detection systems |
| 10/08/2003 | EP1350105A2 Immunoassays for anti-hcv antibodies |
| 10/08/2003 | EP1350104A2 Presenilin enhancers |
| 10/08/2003 | EP1350102A2 Detection of analytes |
| 10/08/2003 | EP1350101A2 Morphometric tissue or cell preparation |
| 10/08/2003 | EP1350100A2 Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients |
| 10/08/2003 | EP1350099A1 Device for measuring blood coagulation and method thereof |